Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Teresa Seville

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Idcases|March 4, 2022
Cerebral abscess with <i>Streptococcus intermedius</i> as a complication of pelvic inflammatory disease in the setting of intrauterine device useSimran Gupta, Sabirah N Kasule, Maria Teresa Seville
Antimicrobial Agents and Chemotherapy|November 27, 2013
Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumoniaBenjamin Dangerfield, Andrew Chung, Brandon Webb, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 28, 2022
Impact of a vancomycin-resistant <i>Enterococcus</i> (VRE) screening result on appropriateness of antibiotic therapyJenna L Reynolds, Raelene E Trudeau, Maria Teresa Seville, et al.
Transplantation|October 28, 2022
Outcomes of Nocardiosis and Treatment of Disseminated Infection in Solid Organ Transplant RecipientsZachary A Yetmar, Douglas W Challener, Maria Teresa Seville, et al.
Transplantation|April 26, 2011
Reactivation of coccidioidomycosis despite antifungal prophylaxis in solid organ transplant recipientsDavid W Keckich, Janis E Blair, Holenarasipur R Vikram, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2011
Treatment of refractory coccidioidomycosis with voriconazole or posaconazoleMichelle M Kim, Holenarasipur R Vikram, Shimon Kusne, et al.
American Journal of Infection Control|November 25, 2017
Screening for Clostridium difficile colonization on admission to a hematopoietic stem cell transplant unit may reduce hospital-acquired C difficile infectionJanice Cho, Maria Teresa Seville, Sahil Khanna, et al.
Transplantation and Cellular Therapy|December 16, 2022
Risk Factors and Outcomes of Nocardiosis in Hematopoietic Stem Cell Transplantation RecipientsZachary A Yetmar, Matthew J Thoendel, Wendelyn Bosch, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 18, 2022
Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epochZachary A Yetmar, Elena Beam, John C O'Horo, et al.
Infection Control and Hospital Epidemiology|November 26, 2024
Positive impact of a diagnostic stewardship intervention on syndromic panel ordering practices and inappropriate <i>C. difficile</i> treatmentDan Ilges, Erin H Graf, Leah Grant, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Idcases|March 4, 2022
Cerebral abscess with <i>Streptococcus intermedius</i> as a complication of pelvic inflammatory disease in the setting of intrauterine device useSimran Gupta, Sabirah N Kasule, Maria Teresa Seville
Antimicrobial Agents and Chemotherapy|November 27, 2013
Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumoniaBenjamin Dangerfield, Andrew Chung, Brandon Webb, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|September 28, 2022
Impact of a vancomycin-resistant <i>Enterococcus</i> (VRE) screening result on appropriateness of antibiotic therapyJenna L Reynolds, Raelene E Trudeau, Maria Teresa Seville, et al.
Transplantation|October 28, 2022
Outcomes of Nocardiosis and Treatment of Disseminated Infection in Solid Organ Transplant RecipientsZachary A Yetmar, Douglas W Challener, Maria Teresa Seville, et al.
Transplantation|April 26, 2011
Reactivation of coccidioidomycosis despite antifungal prophylaxis in solid organ transplant recipientsDavid W Keckich, Janis E Blair, Holenarasipur R Vikram, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2011
Treatment of refractory coccidioidomycosis with voriconazole or posaconazoleMichelle M Kim, Holenarasipur R Vikram, Shimon Kusne, et al.
American Journal of Infection Control|November 25, 2017
Screening for Clostridium difficile colonization on admission to a hematopoietic stem cell transplant unit may reduce hospital-acquired C difficile infectionJanice Cho, Maria Teresa Seville, Sahil Khanna, et al.
Transplantation and Cellular Therapy|December 16, 2022
Risk Factors and Outcomes of Nocardiosis in Hematopoietic Stem Cell Transplantation RecipientsZachary A Yetmar, Matthew J Thoendel, Wendelyn Bosch, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 18, 2022
Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epochZachary A Yetmar, Elena Beam, John C O'Horo, et al.
Infection Control and Hospital Epidemiology|November 26, 2024
Positive impact of a diagnostic stewardship intervention on syndromic panel ordering practices and inappropriate <i>C. difficile</i> treatmentDan Ilges, Erin H Graf, Leah Grant, et al.
Pageof 4